ClinicalTrials.Veeva

Menu

Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults

P

Pusan National University Yangsan Hospital

Status

Enrolling

Conditions

Liver Diseases

Treatments

Dietary Supplement: Placebo group
Dietary Supplement: Panax Ginseng C.A. Mey Extract group

Study type

Interventional

Funder types

Other

Identifiers

NCT03775837
02-2018-031

Details and patient eligibility

About

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Panax Ginseng C.A. Mey Extract on liver function in adults for 8 weeks.

Full description

Previous studies have indicated that Panax Ginseng C.A. Mey Extract may have the ability to improve liver function. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the Panax Ginseng C.A. Mey Extract on liver function in adults; the safety of the compound are also evaluate. The Investigators examine AST, ALT, GGT, and other metabolic parameters at baseline, as well as after 4 and 8 weeks of intervention. Sixty adults were administered either 600 mg of Panax Ginseng C.A. Mey Extract or a placebo each day for 8 weeks;

Enrollment

60 estimated patients

Sex

All

Ages

19 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • ALT ranging from upper limit of reference to three times of upper limit

Exclusion criteria

  • Abnormal liver or renal function (i.e., serum aminotransferase activity > 3 times of upper limit of reference range and serum creatinine concentrations > 1.2 mg/dL)
  • Diabetes (diagnosed clinically or fasting glucose level > 126 mg/dL)
  • History of viral hepatitis or cancer
  • Uncontrolled hypertension
  • History of serious cardiac disease such as angina or myocardial infarction
  • History of gastrectomy
  • History of medication for psychiatric disease
  • Administration of oriental medicine including herbs within the past 4 weeks

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups, including a placebo group

Panax Ginseng C.A. Mey Extract group
Experimental group
Description:
This group takes Panax Ginseng C.A. Mey Extract for 8 weeks
Treatment:
Dietary Supplement: Panax Ginseng C.A. Mey Extract group
Placebo group
Placebo Comparator group
Description:
This group takes placebo for 8 weeks
Treatment:
Dietary Supplement: Placebo group

Trial contacts and locations

1

Loading...

Central trial contact

Sang Yeoup Lee; Ye Li Lee

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems